Glucose metabolism inhibitor PFK-015 combined with immune checkpoint inhibitor is an effective treatment regimen in cancer-Reference-Cited by-同舟云学术

Glucose metabolism inhibitor PFK-015 combined with immune checkpoint inhibitor is an effective treatment regimen in cancer

Published:2022-05-25 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Zheng Jia Bo¹^ORCID,Wong Chau Wei¹,Liu Jia¹,Luo Xiao-Jing¹,Zhou Wei-Yi¹,Chen Yan-Xing¹,Luo Hui-Yan¹²,Zeng Zhao-Lei¹²,Ren Chao¹,Xie Xiao-Ming¹,Wang De-Shen¹²

Affiliation:

1. State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

2. Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, P. R. China

Funder

Science and Technology Program of Guangdong

CAMS Innovation Fund for Medical Sciences

Guangzhou Municipal Science and Technology Project

Science and Technology Planning Project of Guangdong Province

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2079182